Sukino has secured a $31 million investment to enhance its rehabilitative care services in India, addressing the rising demand for long-term recovery support for patients with acute diseases.
Information on the Target
Sukino is addressing the growing demand for rehabilitative care in India, particularly among patients suffering from acute diseases such as strokes, cancer, and orthopedic conditions. Founded in 2016, the company currently operates over 850 beds across eleven centers strategically located in Bangalore, Kochi, and Coimbatore. These facilities aim to provide structured and affordable recovery support, enabling patients to lead fuller lives during their rehabilitation process.
Each Sukino center focuses predominantly on stroke patients, while also accommodating individuals requiring rehabilitation for neurological, orthopedic, and oncology disorders. The company's approach includes both in-facility care and managed home care, ensuring that patients receive a cost-effective, protocol-driven, and reliable recovery framework.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in India
India faces a rising challenge with acute diseases, accounting for approximately 10% of global stroke cases annually. This statistic is exacerbated by lifestyle factors such as obesity, sedentary lifestyles, hypertension
Similar Deals
Accel, IDG Ventures, Endiya Partners, Pi Ventures, VH Capital, Axilor Ventures, Binny Bansal → SigTuple
2023
Life Insurance Corporation of India → Sun Pharmaceutical Industries
2026
not specified
invested in
Sukino
in
in a Series B deal
Disclosed details
Transaction Size: $31M